Next video:
Loading the player...

Game theory in general looks at how individuals or groups make choices that will, in turn, affect other parties' choices. Nash Equilibrium refers to a condition in which every participant has optimized its outcome, based on the other players' expected decision.
 
In summary, game theorists look at decisions, not in isolation, but as part of a system of interactions.

Related Articles
  1. Investing

    Game Theory: Beyond The Basics

    Take your game theory knowledge to the next level by learning about simultaneous games and the Nash Equilibrium.
  2. Insights

    Will Gilead Make a Good Fit for Allergan? (GILD)

    Allergan made two recent acquisitions in the NASH diseases space, and Gilead’s strong NASH drug portfolio can fit well with these.
  3. Investing

    A New CEO Takes the Reins at CarMax

    CarMax (NYSE: KMX) is driving into September with a new executive at the wheel. Bill Nash began his reign as CEO at the beginning of the month, succeeding the freshly retired Tom Folliard. Nash ...
  4. Insights

    5 Nobel Prize-Winning Economic Theories You Should Know About

    Here are 5 prize-winning economic theories that you’ll want to be familiar with.
  5. Insights

    The Basics Of Game Theory

    Break down and examine the potential consequences of economic/financial scenarios.
  6. Insights

    Drugmakers Eye $35B Market Amid Obesity Crisis

    Some large drug companies are working hard to develop a treatment that could generate a big payout.
  7. Investing

    Gilead Sciences to Focus on NASH and HIV Drugs

    Gilead will continue to develop NASH and HIV drugs in 2017.
  8. Insights

    Game Theory And The Greece Bank Crisis

    How can game theory help us understand how the Greece bank crisis will play out? As things come to a head, Greece and the Europeans are trying to hold out.
  9. Investing

    Will This Drug Beat Gilead to Market in NASH? (GILD, ICPT)

    A race of sorts is on between Gilead Sciences (NASDAQ: GILD) and Intercept Pharmaceuticals (NASDAQ: ICPT). In a bid to be the first to win approval for a medicine for the treatment of nonalcoholic ...
  10. Investing

    Gilead Pays $200M Milestone for Liver Drug (GILD)

    Gilead Sciences made a $200 million milestone payment to Nimbus Therapeutics for its drug to treat fatty liver disease.
Hot Definitions
  1. Dividend Yield

    A financial ratio that shows how much a company pays out in dividends each year relative to its share price.
  2. Fixed-Income Security

    An investment that provides a return in the form of fixed periodic payments and the eventual return of principal at maturity. ...
  3. Free Cash Flow - FCF

    A measure of financial performance calculated as operating cash flow minus capital expenditures. Free cash flow (FCF) represents ...
  4. Leverage Ratio

    Any ratio used to calculate the financial leverage of a company to get an idea of the company's methods of financing or to ...
  5. Two And Twenty

    A type of compensation structure that hedge fund managers typically employ in which part of compensation is performance based. ...
  6. Market Capitalization

    The total dollar market value of all of a company's outstanding shares. Market capitalization is calculated by multiplying ...
Trading Center